Joint Pain

Most older adults with joint pain feel they can manage said pain without physician assistance, while 66% report they treat their joint pain with over-the-counter drugs such as acetaminophen or ibuprofen, according to a poll.

Adults with rheumatoid arthritis who adopted a vegan diet experienced improved joint pain, lower cholesterol and weight loss, according to a small, randomized study published in the American Journal of Lifestyle Medicine.

Analgesic opioid use was higher among individuals with psoriasis and those with concomitant psoriasis and psoriatic arthritis compared with the general population, according to findings from a cross-sectional study conducted in Denmark.

Two dosing regimens of tanezumab yielded comparable outcomes in pain and function as NSAIDs across a number of osteoarthritis patient subgroups, according to a speaker at the 2021 OARSI World Congress virtual meeting.

This year’s iteration of the Great Debate at the OARSI 2021 World Congress centered on the role of nerves in pain, functionality and pathogenesis of osteoarthritis.

On May 9, 2020, BoneSmart will host its annual Joint Replacement Awareness Day, a free online educational web event geared toward patients with joint pain who are considering, planning or have had joint replacement surgery.

MAUI, Hawaii — Although traditionally marked by scant changes in treatment and diagnosis from its prehistoric roots, the field of rheumatology experienced a windfall of “disruptive innovation” following World War II — an unlikely catalyst that also revolutionized surfing technology, according to a unique “Hawaiian TED Talk” presented at the 2020 Rheumatology Winter Clinical Symposium.

Treatment options for rheumatoid arthritis have changed drastically over the past 30 years, but some of today’s rheumatologists can still remember studying — and, more rarely, using — gold injections as a treatment for RA. A peek into the history of this treatment reveals a treasure trove of interesting ideas that connected various gold treatments to rheumatology, despite the often toxic results.

Officials from the Nebraska Department of Health and Human Services have issued a public health advisory following multiple reports of serious adverse events in patients who were treated with unapproved stem cell products, particularly those marketed as containing exosomes.

Learning Objective: